Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Willems, SM"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 58
Tytuł:
Jaw Bone Invasion of Oral Squamous Cell Carcinoma Is Associated with Osteoclast Count and Expression of Its Regulating Proteins in Patients and Organoids.
Autorzy:
de Kort WWB; Department of Pathology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Department of Oral and Maxillofacial Surgery & Special Dental Care, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Haakma WE; Department of Pathology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
van Es RJJ; Department of Oral and Maxillofacial Surgery & Special Dental Care, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Department of Head and Neck Surgical Oncology, Utrecht Cancer Center, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Gawlitta D; Department of Oral and Maxillofacial Surgery & Special Dental Care, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Driehuis E; Hubrecht Institute, Developmental Biology & Stem Cell Research, 3584 CT Utrecht, The Netherlands.
Gansevoort M; Department of Pathology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Willems SM; Department of Pathology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2023 Sep 18; Vol. 12 (18). Date of Electronic Publication: 2023 Sep 18.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tumor Markers and Their Prognostic Value in Sinonasal ITAC/Non-ITAC.
Autorzy:
Veuger J; Department of Otorhinolaryngology/Head and Neck Surgery, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.
Kuipers NC; Department of Otorhinolaryngology/Head and Neck Surgery, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.; Department of Surgery, St. Antonius Hospital, 3543 AZ Utrecht, The Netherlands.
Willems SM; Department of Pathology, University Medical Center Groningen, University of Groningen, 9723 GZ Groningen, The Netherlands.
Halmos GB; Department of Otorhinolaryngology/Head and Neck Surgery, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Jun 15; Vol. 15 (12). Date of Electronic Publication: 2023 Jun 15.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Validation of automated positive cell and region detection of immunohistochemically stained laryngeal tumor tissue using digital image analysis.
Autorzy:
Smits HJG; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, the Netherlands.
Swartz JE; Department of Otorhinolaryngology - Head and Neck Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
Philippens MEP; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, the Netherlands.
de Bree R; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
Kaanders JHAM; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
Koppes SA; Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Breimer GE; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Willems SM; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, the Netherlands.
Pokaż więcej
Źródło:
Journal of pathology informatics [J Pathol Inform] 2023 Jan 29; Vol. 14, pp. 100198. Date of Electronic Publication: 2023 Jan 29 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Association of histological features with laryngeal squamous cell carcinoma recurrences: a population-based study of 1502 patients in the Netherlands.
Autorzy:
Ruiter LN; Department of Pathology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht, 3584 CX, the Netherlands. .
van Dijk BAC; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Bruggink AH; Nationwide Network and Registry of Histo- and Cytopathology in the Netherlands (PALGA Foundation), De Bouw 123, Houten, 3991 SZ, the Netherlands.
Doornaert PAH; Department of Radiotherapy, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht, 3584 CX, the Netherlands.
Philippens MEP; Department of Radiotherapy, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht, 3584 CX, the Netherlands.
de Bree R; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht, 3584 CX, the Netherlands.
van Gils CH; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht, 3584 CX, the Netherlands.
Willems SM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht, 3584 CX, the Netherlands.; Present address: Department of Pathology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen, 9713 GZ, the Netherlands.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Apr 22; Vol. 22 (1), pp. 444. Date of Electronic Publication: 2022 Apr 22.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Head and Neck Neoplasms*/pathology
Laryngeal Neoplasms*/pathology
Humans ; Neoplasm Invasiveness/pathology ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Netherlands/epidemiology ; Prognosis ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Detection of NTRK Fusions and TRK Expression and Performance of pan-TRK Immunohistochemistry in Routine Diagnostics: Results from a Nationwide Community-Based Cohort.
Autorzy:
Koopman B; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Kuijpers CCHJ; Foundation PALGA, De Bouw 123, 3991 SZ Houten, The Netherlands.
Groen HJM; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Timens W; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Schuuring E; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Willems SM; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
van Kempen LC; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Pokaż więcej
Źródło:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2022 Mar 09; Vol. 12 (3). Date of Electronic Publication: 2022 Mar 09.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era.
Autorzy:
Saba NF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
Vijayvargiya P; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
Vermorken JB; Department of Medical Oncology, Antwerp University Hospital, 2650 Edegem, Belgium.; Faculty of Medicine and Health Sciences, University of Antwerp, 2650 Antwerp, Belgium.
Rodrigo JP; Department of Otolaryngology, Hospital Universitario Central de Asturias, University of Oviedo, ISPA, IUOPA, CIBERONC, 33011 Oviedo, Spain.
Willems SM; Department of Pathology and Medical Biology, University Medical Center Groningen, 9727 GZ Groningen, The Netherlands.
Zidar N; Faculty of Medicine, Institute of Pathology, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.
de Bree R; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Mäkitie A; Department of Otorhinolaryngology-Head and Neck Surgery, HUS Helsinki University Hospital, University of Helsinki, FI-00029 Helsinki, Finland.
Wolf GT; Department of Otolaryngology-Head and Neck Surgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Argiris A; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Teng Y; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
Ferlito A; International Head and Neck Scientific Group, 35100 Padua, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Feb 25; Vol. 14 (5). Date of Electronic Publication: 2022 Feb 25.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
First experiences with Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancer.
Autorzy:
Klein Nulent TJW; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, P.O. Box 85500, Heidelberglaan 100, 3508 GA, Utrecht, The Netherlands. .; Department of Oral and Maxillofacial Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. .
van Es RJJ; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, P.O. Box 85500, Heidelberglaan 100, 3508 GA, Utrecht, The Netherlands.; Department of Oral and Maxillofacial Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Willems SM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands.
Braat AJAT; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Devriese LA; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
de Bree R; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, P.O. Box 85500, Heidelberglaan 100, 3508 GA, Utrecht, The Netherlands.
de Keizer B; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
EJNMMI research [EJNMMI Res] 2021 Dec 14; Vol. 11 (1), pp. 126. Date of Electronic Publication: 2021 Dec 14.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Hidden Link of Exosomes to Head and Neck Cancer.
Autorzy:
Teng Y; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Gao L; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, College of Pharmacy, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Loveless R; Department of Oral Biology and Diagnostic Sciences, Augusta University, Augusta, GA 30912, USA.
Rodrigo JP; Department of Otolaryngology, Hospital Universitario Central de Asturias (HUCA), Instituto Universitario de Oncología del Principado de Asturias (IUOPA), University of Oviedo, 33011 Oviedo, Spain.; Spanish Biomedical Research Network Centre in Oncology, CIBERONC, 28029 Madrid, Spain.
Strojan P; Department of Radiation Oncology, Institute of Oncology Ljubljana and Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
Willems SM; Department of Pathology and Medical Biology, University of Groningen, 9727 Groningen, The Netherlands.
Nathan CA; Department of Otolaryngology-Head and Neck Surgery, Louisiana State University-Health Shreveport, Shreveport, LA 71103, USA.
Mäkitie AA; Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, FI-00029 Helsinki, Finland.
Saba NF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Ferlito A; Coordinator of the International Head and Neck Scientific Group, 35125 Padua, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Nov 19; Vol. 13 (22). Date of Electronic Publication: 2021 Nov 19.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
False-negative programmed death-ligand 1 immunostaining in ethanol-fixed endobronchial ultrasound-guided transbronchial needle aspiration specimens of non-small-cell lung cancer patients.
Autorzy:
Koomen BM; Department of Pathology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
Vreuls W; Department of Pathology, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands.
de Boer M; Department of Pathology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
de Ruiter EJ; Department of Pathology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
Hoelters J; Department of Pulmonology, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands.
Vink A; Department of Pathology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
Willems SM; Department of Pathology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.; Department of Pathology and Medical Biology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2021 Oct; Vol. 79 (4), pp. 480-490. Date of Electronic Publication: 2021 Jun 08.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*
Lung Neoplasms*
B7-H1 Antigen/*analysis
Biomarkers, Tumor/*analysis
Tissue Fixation/*methods
Endoscopic Ultrasound-Guided Fine Needle Aspiration/methods ; Ethanol ; False Negative Reactions ; Humans ; Immunohistochemistry/methods ; Organ Preservation Solutions
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic Target.
Autorzy:
Emanuel O; UCL Cancer Institute, University College London, London WC1E 6BT, UK.
Liu J; UCL Cancer Institute, University College London, London WC1E 6BT, UK.
Schartinger VH; Department of Otorhinolaryngology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Nei WL; National Cancer Centre, Divisions of Radiation Oncology and Medical Sciences, Singapore 169610, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore 169857, Singapore.
Chan YY; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong 999077, China.; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong 999077, China.
Tsang CM; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong 999077, China.; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong 999077, China.
Riechelmann H; Department of Otorhinolaryngology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Masterson L; Department of Otolaryngology, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Haybaeck J; Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Oppermann U; Botnar Research Centre, University of Oxford, Oxford OX1 2JD, UK.; Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg, 79085 Freiburg, Germany.
Willems SM; Department of Pathology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Department of Pathology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
Ooft ML; Department of Pathology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; King's College Hospitals, NHS Foundation Trust, London SE5 9RS, UK.
Wollmann G; Institute of Virology and Christian Doppler Laboratory for Viral Immunotherapy of Cancer, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Howard D; ENT Department, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London W6 9EP, UK.; Royal National Throat, Nose and Ear Hospital, University College London Hospitals NHS Trust, London WC1E 6DG, UK.
Vanhaesebroeck B; UCL Cancer Institute, University College London, London WC1E 6BT, UK.
Lund VJ; UCL Cancer Institute, University College London, London WC1E 6BT, UK.; Royal National Throat, Nose and Ear Hospital, University College London Hospitals NHS Trust, London WC1E 6DG, UK.
Royle G; UCL Cancer Institute, University College London, London WC1E 6BT, UK.
Chua MLK; National Cancer Centre, Divisions of Radiation Oncology and Medical Sciences, Singapore 169610, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore 169857, Singapore.
Lo KW; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong 999077, China.; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong 999077, China.
Busson P; CNRS-UMR 9018-Metsy, Gustave Roussy and Université Paris-Saclay, 94805 Villejuif, France.
Lechner M; UCL Cancer Institute, University College London, London WC1E 6BT, UK.; Rhinology & Endoscopic Skull Base Surgery, Department of Otolaryngology-H&N Surgery, Stanford University School of Medicine, Palo Alto, CA 94305, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Sep 30; Vol. 13 (19). Date of Electronic Publication: 2021 Sep 30.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses.
Autorzy:
Koopman B; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Cajiao Garcia BN; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Kuijpers CCHJ; Foundation PALGA, De Bouw 123, 3991 SZ Houten, The Netherlands.
Damhuis RAM; Netherlands Comprehensive Cancer Organisation (IKNL), P.O. Box 19079, 3501 DB Utrecht, The Netherlands.
van der Wekken AJ; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Groen HJM; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Schuuring E; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Willems SM; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
van Kempen LC; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Jul 20; Vol. 13 (14). Date of Electronic Publication: 2021 Jul 20.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma.
Autorzy:
Theelen WSME; Department of Thoracic Oncology, The Netherlands Cancer Institute, Postbus 90203, 1006 BE, Amsterdam, The Netherlands. .
Krijgsman O; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Monkhorst K; Division of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Kuilman T; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Neogene Therapeutics, Amsterdam, The Netherlands.
Peters DDGC; Core Facility Molecular Pathology & Biobanking, Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Cornelissen S; Core Facility Molecular Pathology & Biobanking, Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Ligtenberg MA; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Willems SM; Department of Pathology, University Medical Centre Groningen, Groningen, The Netherlands.
Blaauwgeers JLG; Department of Pathology, OLVG LAB BV, Amsterdam, The Netherlands.
van Noesel CJM; Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands.
Peeper DS; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
van den Heuvel MM; Department of Pulmonology, Radboud University Medical Center, Nijmegen, The Netherlands.
Schulze K; Oncology Biomarker Development, Genentech Inc, South San Francisco, USA.
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2020 Jul 03; Vol. 18 (1), pp. 271. Date of Electronic Publication: 2020 Jul 03.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Squamous Cell*/genetics
Lung Neoplasms*/genetics
Humans ; Prognosis ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Elective Neck Dissection or Sentinel Lymph Node Biopsy in Early Stage Oral Cavity Cancer Patients: The Dutch Experience.
Autorzy:
den Toom IJ; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Boeve K; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
Lobeek D; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Bloemena E; Department of Oral and Maxillofacial Surgery/Oral Pathology, Amsterdam UMC/Academic Centre for Dentistry (ACTA), 1081 HV Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC (location VU Medical Center), 1081 HV Amsterdam, The Netherlands.
Donswijk ML; Department of Nuclear Medicine, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
de Keizer B; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Klop WMC; Department of Head and Neck Surgery, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Leemans CR; Department of Otolaryngology-Head and Neck Surgery, Amsterdam UMC (location VU University Medical Center), 1081 HV Amsterdam, The Netherlands.
Willems SM; Department of Pathology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Department of Pathology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
Takes RP; Department of Otolaryngology-Head and Neck Surgery, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Witjes MJH; Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
de Bree R; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Jul 03; Vol. 12 (7). Date of Electronic Publication: 2020 Jul 03.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prostate-specific membrane antigen (PSMA) expression in adenoid cystic carcinoma of the head and neck.
Autorzy:
Klein Nulent TJW; Department of Head and Neck Surgical Oncology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Heidelberglaan 100, P.O. Box 85500, Utrecht, 3508, GA, The Netherlands. .; Department of Oral and Maxillofacial Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. .
Valstar MH; Department of Head and Neck Oncology and Surgery, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Smit LA; Department of Pathology, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Smeele LE; Department of Head and Neck Oncology and Surgery, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Zuithoff NPA; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
de Keizer B; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
de Bree R; Department of Head and Neck Surgical Oncology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Heidelberglaan 100, P.O. Box 85500, Utrecht, 3508, GA, The Netherlands.
van Es RJJ; Department of Head and Neck Surgical Oncology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Heidelberglaan 100, P.O. Box 85500, Utrecht, 3508, GA, The Netherlands.; Department of Oral and Maxillofacial Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Willems SM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2020 Jun 05; Vol. 20 (1), pp. 519. Date of Electronic Publication: 2020 Jun 05.
Typ publikacji:
Journal Article
MeSH Terms:
Antigens, Surface/*metabolism
Carcinoma, Adenoid Cystic/*pathology
Glutamate Carboxypeptidase II/*metabolism
Head and Neck Neoplasms/*pathology
Neoplasm Recurrence, Local/*pathology
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Adenoid Cystic/mortality ; Disease-Free Survival ; Female ; Head and Neck Neoplasms/mortality ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Staging ; Netherlands/epidemiology ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparability of PD-L1 immunohistochemistry assays for non-small-cell lung cancer: a systematic review.
Autorzy:
Koomen BM; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Badrising SK; Department of Pulmonary Diseases, Radboudumc, Nijmegen, the Netherlands.
van den Heuvel MM; Department of Pulmonary Diseases, Radboudumc, Nijmegen, the Netherlands.
Willems SM; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2020 May; Vol. 76 (6), pp. 793-802. Date of Electronic Publication: 2020 Mar 24.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
B7-H1 Antigen/*analysis
Biomarkers, Tumor/*analysis
Carcinoma, Non-Small-Cell Lung/*diagnosis
Immunohistochemistry/*methods
Lung Neoplasms/*diagnosis
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genome-wide Association Study of Change in Fasting Glucose over time in 13,807 non-diabetic European Ancestry Individuals.
Autorzy:
Liu CT; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, MA, 02118, USA. .
Merino J; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Programs in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA.
Rybin D; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, MA, 02118, USA.
DiCorpo D; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, MA, 02118, USA.
Benke KS; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Bragg-Gresham JL; Kidney Epidemiology and Cost Center, Department of Internal Medicine - Nephrology, University of Michigan, Ann Arbor, MI, 48109, USA.
Canouil M; CNRS UMR 8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, University of Lille, 59000, Lille, France.
Corre T; Institute of Social and Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland.; Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Grallert H; Research Unit of Molecular Epidemiology, Institute of Epidemiology, Helmholtz Zentrum München Research Center for Environmental Health, Neuherberg, Germany.; German Center for Diabetes Research (DZD), Neuherberg, Germany.
Isaacs A; Genetic Epidemiology Unit, Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.; CARIM School for Cardiovascular Diseases, Maastricht Centre for Systems Biology (MaCSBio) and Department of Biochemistry, Maastricht University, Maastricht, The Netherlands.
Kutalik Z; Institute of Social and Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Lahti J; Helsinki Collegium for Advanced Studies, University of Helsinki, Helsinki, Finland.; Department of Psychology and Logopedics, University of Helsinki, Helsinki, Finland.
Marullo L; Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
Marzi C; Research Unit of Molecular Epidemiology, Institute of Epidemiology, Helmholtz Zentrum München Research Center for Environmental Health, Neuherberg, Germany.; German Center for Diabetes Research (DZD), Neuherberg, Germany.
Rasmussen-Torvik LJ; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Rocheleau G; CNRS UMR 8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, University of Lille, 59000, Lille, France.; Preventive and Genomic Cardiology, McGill University Health Centre and Research Institute, Montreal, Quebec, Canada.; The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; The Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Rueedi R; Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Scapoli C; Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
Verweij N; University Medical Center Groningen, Department of Cardiology, University of Groningen, Groningen, The Netherlands.
Vogelzangs N; Maastricht University, Department of Epidemiology, Cardiovascular Research Institute Maastricht (CARIM) & Maastricht Centre for Systems Biology (MaCSBio), Maastricht, The Netherlands.
Willems SM; Genetic Epidemiology Unit, Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Yengo L; CNRS UMR 8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, University of Lille, 59000, Lille, France.
Bakker SJL; University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, The Netherlands.
Beilby J; PathWest Laboratory Medicine of Western Australia, Nedlands WA, 6009, Australia.; School of Pathology and Laboratory Medicine, The University of Western Australia, Nedlands WA, 6009, Australia.; Busselton Population Medical Research Foundation, Sir Charles Gairdner Hospital, Nedlands WA, Australia.
Hui J; PathWest Laboratory Medicine of Western Australia, Nedlands WA, 6009, Australia.; School of Pathology and Laboratory Medicine, The University of Western Australia, Nedlands WA, 6009, Australia.; Busselton Population Medical Research Foundation, Sir Charles Gairdner Hospital, Nedlands WA, Australia.; School of Population and Global Health, The University of Western Australia, Nedlands WA, 6009, Australia.
Kajantie E; National Institute for Health and Welfare, Helsinki, Finland.
Müller-Nurasyid M; Institute of Genetic Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.; Department of Medicine I, University Hospital Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany.; Institute of Medical Informatics, Biometry and Epidemiology, Chair of Genetic Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany.; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Rathmann W; Institute for Biometrics and Epidemiology, German Diabetes Centre, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Auf'm Hennekamp 65, 40225, Düsseldorf, Germany.
Balkau B; CESP Centre for Research in Epidemiology and Population Health, Villejuif, France.; Univ. Paris-Saclay, Univ. Paris Sud, UVSQ, UMRS 1018, F-94807, Villejuif, France.; INSERM U1018, CESP, Renal and Cardiovascular Epidemiology, UVSQ-UPS, Villejuif, France.
Bergmann S; Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Department of Integrative Biomedical Sciences, University of Cape Town, Cape Town, South Africa.
Eriksson JG; National Institute for Health and Welfare, Helsinki, Finland.; Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland.; Folkhälsan Research Centre, Helsinki, Finland.
Florez JC; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Programs in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.
Froguel P; CNRS UMR 8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, University of Lille, 59000, Lille, France.; Department of Genomics of Common Disease, Imperial College London, London, United Kingdom.
Harris T; National Institute on Aging, Laboratory of Epidemiology and Population Sciences in Intramural Research Program, Baltimore, MD, USA.
Hung J; Busselton Population Medical Research Foundation, Sir Charles Gairdner Hospital, Nedlands WA, Australia.; School of Medicine and Pharmacology, The University of Western Australia, Nedlands WA, 6009, Australia.
James AL; Busselton Population Medical Research Foundation, Sir Charles Gairdner Hospital, Nedlands WA, Australia.; School of Medicine and Pharmacology, The University of Western Australia, Nedlands WA, 6009, Australia.; Department of Pulmonary Physiology, Sir Charles Gairdner Hospital, Nedlands WA, 6009, Australia.
Kavousi M; Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Miljkovic I; Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA.
Musk AW; Busselton Population Medical Research Foundation, Sir Charles Gairdner Hospital, Nedlands WA, Australia.; School of Population and Global Health, The University of Western Australia, Nedlands WA, 6009, Australia.; School of Medicine and Pharmacology, The University of Western Australia, Nedlands WA, 6009, Australia.
Palmer LJ; School of Public Health, University of Adelaide, Adelaide, Australia.
Peters A; German Center for Diabetes Research (DZD), Neuherberg, Germany.; Institute of Epidemiology, Helmholtz Zentrum München Research Center for Environmental Health, Neuherberg, Germany.
Roussel R; INSERM U1138 (équipe 2: Pathophysiology and Therapeutics of Vascular and Renal Diseases Related to Diabetes, Centre de Recherches des Cordeliers), Paris, France.; Univ. Paris 7 Denis Diderot, Sorbonne Paris Cité, France.; AP-HP, DHU FIRE, Department of Endocrinology, Diabetology, Nutrition, and Metabolic Diseases, Bichat Claude Bernard Hospital, Paris, France.
van der Harst P; University Medical Center Groningen, Department of Cardiology, University of Groningen, Groningen, The Netherlands.; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.; Durrer Center for Cardiogenetic Research, ICIN-Netherlands Heart Institute, Utrecht, The Netherlands.
van Duijn CM; Genetic Epidemiology Unit, Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Vollenweider P; Department of Medicine, Internal Medicine, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Barroso I; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
Prokopenko I; Department of Medicine, Imperial College London, London, United Kingdom.; Wellcome Centre for Human genetics, University of Oxford, Oxford, United Kingdom.; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom.
Dupuis J; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, MA, 02118, USA.; The National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA.
Meigs JB; Programs in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
Bouatia-Naji N; INSERM, UMR970 Paris Cardiovascular Research Center (PARCC), Paris, F-75015, France. .; Paris-Descartes University, Sorbonne Paris Cité, Paris, 75006, France. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Jul 01; Vol. 9 (1), pp. 9439. Date of Electronic Publication: 2019 Jul 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genome-Wide Association Study*
Blood Glucose/*genetics
White People/*genetics
Blood Glucose/analysis ; Diabetes Mellitus, Type 2/genetics ; Female ; Genetic Variation ; Genotype ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Phenotype ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
One-fits-all pretreatment protocol facilitating Fluorescence In Situ Hybridization on formalin-fixed paraffin-embedded, fresh frozen and cytological slides.
Autorzy:
Richardson SO; 1Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Huibers MMH; 1Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.; 2Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
de Weger RA; 1Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.; 3Department of Pathology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
de Leng WWJ; 1Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Hinrichs JWJ; 1Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Meijers RWJ; 1Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Willems SM; 1Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Peeters TLMG; 1Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Molecular cytogenetics [Mol Cytogenet] 2019 Jun 17; Vol. 12, pp. 27. Date of Electronic Publication: 2019 Jun 17 (Print Publication: 2019).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer.
Autorzy:
Theelen WSME; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Kuilman T; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Schulze K; Oncology Biomarker Development, Genentech Inc., South San Francisco, United States of America.
Zou W; Biostatistics, Genentech Inc., South San Francisco, United States of America.
Krijgsman O; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Peters DDGC; Core Facility Molecular Pathology & Biobanking, Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Cornelissen S; Core Facility Molecular Pathology & Biobanking, Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Monkhorst K; Division of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Sarma P; Oncology Biomarker Development, Genentech Inc., South San Francisco, United States of America.
Sumiyoshi T; Oncology Biomarker Development, Genentech Inc., South San Francisco, United States of America.
Amler LC; Oncology Biomarker Development, Genentech Inc., South San Francisco, United States of America.
Willems SM; Department of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Blaauwgeers JLG; Department of Pathology, OLVG, Amsterdam, The Netherlands.
van Noesel CJM; Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands.
Peeper DS; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
van den Heuvel MM; Department of Pulmonology, Radboud University Medical Center, Nijmegen, The Netherlands.
Kowanetz M; Oncology Biomarker Development, Genentech Inc., South San Francisco, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 May 24; Vol. 14 (5), pp. e0216864. Date of Electronic Publication: 2019 May 24 (Print Publication: 2019).
Typ publikacji:
Journal Article
MeSH Terms:
Immunity, Cellular*
B7-H1 Antigen/*immunology
CD8-Positive T-Lymphocytes/*immunology
Carcinoma, Non-Small-Cell Lung/*immunology
Gene Expression Regulation, Neoplastic/*immunology
Interferon-gamma/*immunology
Lung Neoplasms/*immunology
Neoplasm Proteins/*immunology
Signal Transduction/*immunology
Adult ; Aged ; Aged, 80 and over ; B7-H1 Antigen/genetics ; CD8-Positive T-Lymphocytes/pathology ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/pathology ; Female ; Humans ; Interferon-gamma/genetics ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Proteins/genetics ; Neoplasm Staging ; Programmed Cell Death 1 Receptor/genetics ; Programmed Cell Death 1 Receptor/immunology ; Signal Transduction/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prediction of ultrasound guided fine needle aspiration cytology results by FDG PET-CT for lymph node metastases in head and neck squamous cell carcinoma patients.
Autorzy:
Peltenburg B; a Department of Head and Neck Surgical Oncology , University Medical Center, University Utrecht , Utrecht , The Netherlands.; b Department of Radiotherapy , University Medical Center Utrecht, University Utrecht , Utrecht , The Netherlands.
de Keizer B; c Department of Radiology and Nuclear Medicine , University Medical Center Utrecht, University Utrecht , Utrecht , The Netherlands.
Dankbaar JW; c Department of Radiology and Nuclear Medicine , University Medical Center Utrecht, University Utrecht , Utrecht , The Netherlands.
de Boer M; d Department of Pathology , University Medical Center, University Utrecht , Utrecht , The Netherlands.
Willems SM; d Department of Pathology , University Medical Center, University Utrecht , Utrecht , The Netherlands.
Philippens MEP; b Department of Radiotherapy , University Medical Center Utrecht, University Utrecht , Utrecht , The Netherlands.
Terhaard CHJ; b Department of Radiotherapy , University Medical Center Utrecht, University Utrecht , Utrecht , The Netherlands.
de Bree R; a Department of Head and Neck Surgical Oncology , University Medical Center, University Utrecht , Utrecht , The Netherlands.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2018 Dec; Vol. 57 (12), pp. 1687-1692. Date of Electronic Publication: 2018 Nov 29.
Typ publikacji:
Evaluation Study; Journal Article
MeSH Terms:
Endoscopic Ultrasound-Guided Fine Needle Aspiration*/standards
Fluorodeoxyglucose F18*
Lymph Nodes/*pathology
Positron Emission Tomography Computed Tomography/*methods
Squamous Cell Carcinoma of Head and Neck/*diagnosis
Adult ; Cytodiagnosis/methods ; Cytodiagnosis/standards ; Female ; Humans ; Lymphatic Metastasis ; Male ; Multimodal Imaging/methods ; Predictive Value of Tests ; Prognosis ; Retrospective Studies ; Sensitivity and Specificity ; Squamous Cell Carcinoma of Head and Neck/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 58

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies